Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jose Beato-Coelho"'
Autor:
Jorge Pagola, Jesus Juega, Jaume Francisco-Pascual, Angel Moya, Mireia Sanchis, Alejandro Bustamante, Anna Penalba, Maria Usero, Elisa Cortijo, Juan F. Arenillas, Ana I. Calleja, Maria Sandin-Fuentes, Jeronimo Rubio, Fernando Mancha, Irene Escudero-Martinez, Francisco Moniche, Reyes de Torres, Soledad Pérez-Sánchez, Carlos E. González-Matos, Ángela Vega, Alonso A. Pedrote, Eduardo Arana-Rueda, Joan Montaner, Carlos A. Molina, Sara Eichau, Marian Muchada, David Rodriguez-Luna, Noelia Rodriguez, Estela Sanjuan, Marta Rubiera, Sandra Boned, Marc Ribó, Estefania Montiel, Jose Beato-Coelho, Teresa González Alujas, Arturo Evangelista
Publikováno v:
International Journal of Cardiology. 251:45-50
We describe the feasibility of monitoring with a Textile Wearable Holter (TWH) in patients included in Crypto AF registry.We monitored cryptogenic stroke patients from stroke onset (3days) continuously during 28days. We employed a TWH composed by a g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a014804e7dc3555e7f3fb5e83324b949
https://doi.org/10.1016/j.ijcard.2017.10.063
https://doi.org/10.1016/j.ijcard.2017.10.063
Autor:
Miguel Tábuas-Pereira, Sandra Freitas, José Beato-Coelho, Joana Ribeiro, Joana Parra, Cristina Martins, Miguel Silva, Maria Assunção Matos, Ana Rita Nogueira, Fernando Silva, João Sargento-Freitas, Gustavo Cordeiro, Luís Cunha, Isabel Santana
Publikováno v:
Acta Médica Portuguesa, Vol 31, Iss 5, Pp 265-271 (2018)
Introduction: Classical aphasia evaluation scales are too long to use in the context of acute stroke or as a monitoring tool. The Aphasia Rapid Test is a 26-point scale developed as a bedside assessment to rate aphasia severity in acute stroke patien
Externí odkaz:
https://doaj.org/article/05c63265f17649dcbc3830fdb9529673
Autor:
Inês Baldeiras, Isabel Santana, Maria João Leitão, Helena Gens, Rui Pascoal, Miguel Tábuas-Pereira, José Beato-Coelho, Diana Duro, Maria Rosário Almeida, Catarina Resende Oliveira
Publikováno v:
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-15 (2018)
Abstract Background Cerebrospinal fluid (CSF) biomarkers have been used to increase the evidence of underlying Alzheimer’s disease (AD) pathology in mild cognitive impairment (MCI). However, CSF biomarker-based classification often results in confl
Externí odkaz:
https://doaj.org/article/913c676b02e34da0895550fc7436f768